Euan N Paterson1, Chris Cardwell1, Thomas J MacGillivray2, Emanuele Trucco3, Alexander S Doney4, Paul Foster5, Alexander P Maxwell1, Gareth J McKay6. 1. Centre for Public Health, Institute of Clinical Science, Queen's University Belfast, Block B, Royal Hospital, Grosvenor Road, Belfast, Northern Ireland, BT12 6BA. 2. VAMPIRE project, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, Scotland, UK. 3. VAMPIRE project, Computer Vision and Image Processing Group, School of Science and Engineering (Computing), University of Dundee, Dundee, UK. 4. Ninewells Hospital and Medical School, University of Dundee, Dundee, UK. 5. Moorfields Eye Hospital, London, UK. 6. Centre for Public Health, Institute of Clinical Science, Queen's University Belfast, Block B, Royal Hospital, Grosvenor Road, Belfast, Northern Ireland, BT12 6BA. g.j.mckay@qub.ac.uk.
Abstract
BACKGROUND: Associations between microvascular variation and chronic kidney disease (CKD) have been reported previously. Non-invasive retinal fundus imaging enables evaluation of the microvascular network and may offer insight to systemic risk associated with CKD. METHODS: Retinal microvascular parameters (fractal dimension [FD] - a measure of the complexity of the vascular network, tortuosity, and retinal arteriolar and venular calibre) were quantified from macula-centred fundus images using the Vessel Assessment and Measurement Platform for Images of the REtina (VAMPIRE) version 3.1 (VAMPIRE group, Universities of Dundee and Edinburgh, Scotland) and assessed for associations with renal damage in a case-control study nested within the multi-centre UK Biobank cohort study. Participants were designated cases or controls based on urinary albumin to creatinine ratio (ACR) thresholds. Participants with ACR ≥ 3 mg/mmol (ACR stages A2-A3) were characterised as cases, and those with an ACR < 3 mg/mmol (ACR stage A1) were categorised as controls. Participants were matched on age, sex and ethnic background. RESULTS: Lower FD (less extensive microvascular branching) was associated with a small increase in odds of albuminuria independent of blood pressure, diabetes and other potential confounding variables (odds ratio [OR] 1.18, 95% confidence interval [CI] 1.03-1.34 for arterioles and OR 1.24, CI 1.05-1.47 for venules). Measures of tortuosity or retinal arteriolar and venular calibre were not significantly associated with ACR. CONCLUSIONS: This study supports previously reported associations between retinal microvascular FD and other metabolic disturbances affecting the systemic vasculature. The association between retinal microvascular FD and albuminuria, independent of diabetes and blood pressure, may represent a useful indicator of systemic vascular damage associated with albuminuria.
BACKGROUND: Associations between microvascular variation and chronic kidney disease (CKD) have been reported previously. Non-invasive retinal fundus imaging enables evaluation of the microvascular network and may offer insight to systemic risk associated with CKD. METHODS: Retinal microvascular parameters (fractal dimension [FD] - a measure of the complexity of the vascular network, tortuosity, and retinal arteriolar and venular calibre) were quantified from macula-centred fundus images using the Vessel Assessment and Measurement Platform for Images of the REtina (VAMPIRE) version 3.1 (VAMPIRE group, Universities of Dundee and Edinburgh, Scotland) and assessed for associations with renal damage in a case-control study nested within the multi-centre UK Biobank cohort study. Participants were designated cases or controls based on urinary albumin to creatinine ratio (ACR) thresholds. Participants with ACR ≥ 3 mg/mmol (ACR stages A2-A3) were characterised as cases, and those with an ACR < 3 mg/mmol (ACR stage A1) were categorised as controls. Participants were matched on age, sex and ethnic background. RESULTS: Lower FD (less extensive microvascular branching) was associated with a small increase in odds of albuminuria independent of blood pressure, diabetes and other potential confounding variables (odds ratio [OR] 1.18, 95% confidence interval [CI] 1.03-1.34 for arterioles and OR 1.24, CI 1.05-1.47 for venules). Measures of tortuosity or retinal arteriolar and venular calibre were not significantly associated with ACR. CONCLUSIONS: This study supports previously reported associations between retinal microvascular FD and other metabolic disturbances affecting the systemic vasculature. The association between retinal microvascular FD and albuminuria, independent of diabetes and blood pressure, may represent a useful indicator of systemic vascular damage associated with albuminuria.
Authors: Alejandro Rodriguez-Ruiz; Kristina Lång; Albert Gubern-Merida; Mireille Broeders; Gisella Gennaro; Paola Clauser; Thomas H Helbich; Margarita Chevalier; Tao Tan; Thomas Mertelmeier; Matthew G Wallis; Ingvar Andersson; Sophia Zackrisson; Ritse M Mann; Ioannis Sechopoulos Journal: J Natl Cancer Inst Date: 2019-09-01 Impact factor: 13.506
Authors: Vincent Daien; Ryo Kawasaki; Max Villain; Jean Ribstein; Guilhem Du Cailar; Albert Mimran; Pierre Fesler Journal: Acta Ophthalmol Date: 2013-02-14 Impact factor: 3.761
Authors: Laurence Shen Lim; Carol Yim-Lui Cheung; Charumathi Sabanayagam; Su Chi Lim; E Shyong Tai; Lei Huang; Tien Yin Wong Journal: Invest Ophthalmol Vis Sci Date: 2013-04-26 Impact factor: 4.799
Authors: David A Antonetti; Alistair J Barber; Sarah K Bronson; Willard M Freeman; Thomas W Gardner; Leonard S Jefferson; Mark Kester; Scot R Kimball; J Kyle Krady; Kathryn F LaNoue; Christopher C Norbury; Patrick G Quinn; Lakshman Sandirasegarane; Ian A Simpson Journal: Diabetes Date: 2006-09 Impact factor: 9.461
Authors: Charumathi Sabanayagam; Dejiang Xu; Daniel S W Ting; Simon Nusinovici; Riswana Banu; Haslina Hamzah; Cynthia Lim; Yih-Chung Tham; Carol Y Cheung; E Shyong Tai; Ya Xing Wang; Jost B Jonas; Ching-Yu Cheng; Mong Li Lee; Wynne Hsu; Tien Y Wong Journal: Lancet Digit Health Date: 2020-05-12
Authors: Juan E Grunwald; Maxwell Pistilli; Gui-Shuang Ying; Ebenezer Daniel; Maureen Maguire; Dawei Xie; Jason Roy; Revell Whittock-Martin; Candace Parker Ostroff; Joan C Lo; Raymond R Townsend; Crystal A Gadegbeku; James P Lash; Jeffrey C Fink; Mahboob Rahman; Harold I Feldman; John W Kusek Journal: JAMA Ophthalmol Date: 2019-07-01 Impact factor: 7.389
Authors: M Briet; E Bozec; S Laurent; C Fassot; G M London; C Jacquot; M Froissart; P Houillier; P Boutouyrie Journal: Kidney Int Date: 2006-01 Impact factor: 10.612
Authors: Francis H Verbeke; Bruno Pannier; Alain P Guérin; Pierre Boutouyrie; Stephane Laurent; Gérard M London Journal: Clin J Am Soc Nephrol Date: 2011-07-22 Impact factor: 8.237
Authors: Linbin Wu; Xia Gong; Wei Wang; Lei Zhang; Jiachen Zhou; Xi Ming; Meng Yuan; Wenyong Huang; Lanhua Wang Journal: Front Med (Lausanne) Date: 2022-09-02